PMV Pharmaceuticals
Presence
PMV Pharmaceuticals is one of the...
PMV Pharmaceuticals is a company listed under the stock ticker PMVP (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at PMV Pharmaceuticals
- David Mack, Director, President and Chief Executive Officer
- Arnold Levine, Director
- Kirsten Flowers, Director
Popular executive movements at PMV Pharmaceuticals
- Leila Alland, Chief Medical Officer, has left the company (posted on January 21 2024).
- Winston Kung, Chief Operating Officer and Chief Financial Officer, has left the company (posted on January 8 2024).
- Michael Carulli, who was Senior Vice President, Finance, is promoted to Chief Financial Officer (posted on January 8 2024).
Create your alert
to follow the executive moves at PMV Pharmaceuticals.
Pharmaceuticals
PMV Pharmaceuticals has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by PMV Pharmaceuticals
- PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
- PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
- View more press releases Close
Social media about PMV Pharmaceuticals
- PMV Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- PMV Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including David Mack 
Call PMV Pharmaceuticals at +1 609...
